Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Methylation of cancer related genes in tumor and peripheral blood DNA from the same breast cancer patient as two independent events.

Wojdacz TK, Thestrup BB, Overgaard J, Hansen LL.

Diagn Pathol. 2011 Nov 30;6:116. doi: 10.1186/1746-1596-6-116.

2.

Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients.

Sharma G, Mirza S, Parshad R, Srivastava A, Gupta SD, Pandya P, Ralhan R.

Life Sci. 2010 Jul 17;87(3-4):83-91. doi: 10.1016/j.lfs.2010.05.001. Epub 2010 May 12.

PMID:
20470789
3.

Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.

Dulaimi E, Hillinck J, Ibanez de Caceres I, Al-Saleem T, Cairns P.

Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6189-93.

4.

Clinical significance of promoter hypermethylation of RASSF1A, RARbeta2, BRCA1 and HOXA5 in breast cancers of Indian patients.

Bagadi SA, Prasad CP, Kaur J, Srivastava A, Prashad R, Gupta SD, Ralhan R.

Life Sci. 2008 Jun 20;82(25-26):1288-92. doi: 10.1016/j.lfs.2008.04.020. Epub 2008 May 11.

PMID:
18538349
5.

BRCA1 promoter methylation in peripheral blood DNA of mutation negative familial breast cancer patients with a BRCA1 tumour phenotype.

Snell C, Krypuy M, Wong EM; kConFab investigators, Loughrey MB, Dobrovic A.

Breast Cancer Res. 2008;10(1):R12. doi: 10.1186/bcr1858. Epub 2008 Feb 12.

6.

Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas.

Virmani AK, Rathi A, Sathyanarayana UG, Padar A, Huang CX, Cunnigham HT, Farinas AJ, Milchgrub S, Euhus DM, Gilcrease M, Herman J, Minna JD, Gazdar AF.

Clin Cancer Res. 2001 Jul;7(7):1998-2004.

7.

Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients.

Mirza S, Sharma G, Prasad CP, Parshad R, Srivastava A, Gupta SD, Ralhan R.

Life Sci. 2007 Jul 4;81(4):280-7. Epub 2007 May 25.

PMID:
17599361
8.

[Correlation of BRCA1 and APC aberrant methylation with the response to anthracycline-based neoadjuvant chemotherapy in primary breast cancer].

Yuan P, Xu Y, Ouyang T, Wang TF, Fan ZQ, Fan T, Lin BY, Xie YT, Li JF.

Zhonghua Zhong Liu Za Zhi. 2009 Apr;31(4):282-6. Chinese.

PMID:
19615284
9.

Epigenetic alterations by methylation of RASSF1A and DAPK1 promoter sequences in mammary carcinoma detected in extracellular tumor DNA.

Ahmed IA, Pusch CM, Hamed T, Rashad H, Idris A, El-Fadle AA, Blin N.

Cancer Genet Cytogenet. 2010 Jun;199(2):96-100. doi: 10.1016/j.cancergencyto.2010.02.007.

PMID:
20471512
10.

[Detection of free tumor-related DNA in the serum of breast cancer patients].

Zhang JJ, Ouyang T, Wan WH, Deng GR.

Zhonghua Zhong Liu Za Zhi. 2007 Aug;29(8):609-13. Chinese.

PMID:
18210882
11.

Association of folate and other one-carbon related nutrients with hypermethylation status and expression of RARB, BRCA1, and RASSF1A genes in breast cancer patients.

Pirouzpanah S, Taleban FA, Mehdipour P, Atri M.

J Mol Med (Berl). 2015 Aug;93(8):917-34. doi: 10.1007/s00109-015-1268-0. Epub 2015 Mar 25.

PMID:
25805039
12.

[Detection and significance of APC gene promoter hypermethylation in serum of breast cancer patients].

Zhang JJ, Ouyang T, Wan WH, Xu GW, Deng GR.

Ai Zheng. 2007 Jan;26(1):44-7. Chinese.

PMID:
17222366
13.

Silencing of tumor suppressor genes RASSF1A, SLIT2, and WIF1 by promoter hypermethylation in hereditary breast cancer.

Alvarez C, Tapia T, Cornejo V, Fernandez W, Muñoz A, Camus M, Alvarez M, Devoto L, Carvallo P.

Mol Carcinog. 2013 Jun;52(6):475-87. doi: 10.1002/mc.21881. Epub 2012 Feb 7.

PMID:
22315090
14.

[Methylation status and protein expression of adenomatous polyposis coli (APC) gene in breast cancer].

Liu Z, Yang L, Cui DX, Liu BL, Zhang XB, Ma WF, Zhang Q.

Ai Zheng. 2007 Jun;26(6):586-90. Chinese.

PMID:
17562262
15.

Soy phytoestrogens modify DNA methylation of GSTP1, RASSF1A, EPH2 and BRCA1 promoter in prostate cancer cells.

Vardi A, Bosviel R, Rabiau N, Adjakly M, Satih S, Dechelotte P, Boiteux JP, Fontana L, Bignon YJ, Guy L, Bernard-Gallon DJ.

In Vivo. 2010 Jul-Aug;24(4):393-400.

PMID:
20668305
16.

BRCA1 promoter methylation in peripheral blood DNA was identified in sporadic breast cancer and controls.

Bosviel R, Garcia S, Lavediaux G, Michard E, Dravers M, Kwiatkowski F, Bignon YJ, Bernard-Gallon DJ.

Cancer Epidemiol. 2012 Jun;36(3):e177-82. doi: 10.1016/j.canep.2012.02.001. Epub 2012 Mar 7.

PMID:
22402307
17.

Methylation-related mutations in the BRCA1 promoter in peripheral blood cells from cancer-free women.

Al-Moghrabi N, Al-Qasem AJ, Aboussekhra A.

Int J Oncol. 2011 Jul;39(1):129-35. doi: 10.3892/ijo.2011.1021. Epub 2011 Apr 29.

PMID:
21537840
18.

Promoter hypermethylation in benign breast epithelium in relation to predicted breast cancer risk.

Lewis CM, Cler LR, Bu DW, Zöchbauer-Müller S, Milchgrub S, Naftalis EZ, Leitch AM, Minna JD, Euhus DM.

Clin Cancer Res. 2005 Jan 1;11(1):166-72.

19.

Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens.

Rice JC, Ozcelik H, Maxeiner P, Andrulis I, Futscher BW.

Carcinogenesis. 2000 Sep;21(9):1761-5.

PMID:
10964110
20.

The presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patients.

Van der Auwera I, Elst HJ, Van Laere SJ, Maes H, Huget P, van Dam P, Van Marck EA, Vermeulen PB, Dirix LY.

Br J Cancer. 2009 Apr 21;100(8):1277-86. doi: 10.1038/sj.bjc.6605013.

Supplemental Content

Support Center